tiprankstipranks
Trending News
More News >
MaaT Pharma (FR:MAAT)
:MAAT
France Market

MaaT Pharma (MAAT) Income Statement

Compare
3 Followers

MaaT Pharma Income Statement

Last quarter (Q2 2025), MaaT Pharma's total revenue was €2.43M, an increase of 76.12% from the same quarter last year. In Q2, MaaT Pharma's net income was €-15.09M. See MaaT Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 3.22M€ 2.23M€ 1.43M€ 972.00K€ 0.00
Gross Profit
€ 1.97M€ 784.00K€ 1.09M€ 806.00K€ -164.00K
Operating Expenses
€ 30.39M€ 25.39M€ 14.65M€ 9.70M€ 7.22M
Depreciation and Amortization
€ 1.69M€ 871.00K€ 429.00K€ 328.00K€ 164.00K
EBITDA
€ -26.34M€ -22.07M€ -13.10M€ -8.57M€ -6.58M
Operating Income
€ -28.43M€ -19.94M€ -13.56M€ -8.89M€ -7.39M
Other Income/Expenses
€ -3.99M€ 226.00K€ -156.00K€ -126.00K€ 596.00K
Pretax Income
€ -32.42M€ -19.72M€ -13.71M€ -9.02M€ -6.79M
Net Income
€ -28.90M€ -19.72M€ -13.71M€ -9.02M€ -5.35M
Per Share Metrics
Basic EPS
€ -2.20€ -1.73€ -1.39€ -3.72€ -25.68
Diluted EPS
€ -2.20€ -1.73€ -1.39€ -3.72€ -25.68
Weighted Average Shares Outstanding
13.06M 11.37M 9.89M 2.43M 206.46K
Weighted Average Shares Outstanding (Diluted)
13.06M 11.37M 9.89M 2.43M 206.46K
Currency in EUR

MaaT Pharma Earnings and Revenue History